Tetracycline-Regulated Gene Expression in Replication-Incompetent Herpes Simplex Virus Vectors
- 10 December 2002
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 13 (18) , 2113-2124
- https://doi.org/10.1089/104303402320987815
Abstract
Although herpes simplex virus (HSV) vectors appear to have great potential as gene delivery vectors both in vitro and in vivo, the expression of foreign genes in such vectors cannot be easily regulated. Of the known eukaryotic regulatory systems, the tetracycline-inducible gene expression system is perhaps the most widely used because of its induction characteristics and because of the well-known pharmacological properties of tetracycline (Tet) and analogs such as doxycycline. Here, we describe the adaptation of the Tet-inducible system for use in replication-incompetent HSV vectors. HSV vectors were constructed that contained several types of Tet-inducible promoters for foreign gene expression. These promoters contained a tetracycline response element (TRE) linked to either a minimal cytomegalovirus (CMV) immediate-early promoter, a minimal HSV ICP0 promoter, or a truncated HSV ICP0 promoter containing one copy of the HSV TAATGARAT cis-acting immediate-early regulatory element (where R represents a prime base). All three promoter constructs were regulated appropriately by doxycycline, as shown by the expression of the marker gene lacZ in cell lines engineered to express Tet transactivators. The ICP0 promoter constructs expressed the highest and most sustained levels of lacZ, but the CMV promoter construct had the highest relative level of induction, suggesting their use in different applications. To extend the utility of Tet-regulated HSV vectors, vectors were constructed that coexpressed an inducible Tet transactivator in addition to the inducible lacZ marker gene. This modification resulted in tetracycline-inducible gene expression that was not restricted to specific cell lines, and this vector was capable of inducible expression in irreversibly differentiated NT2 cells (NT-neurons) for several days. Finally, HSV vectors were constructed that expressed modified Tet transactivators, resulting in improved induction properties and indicating the flexibility of the Tet-regulated system for regulation of foreign gene expression in HSV vector-infected cells.Keywords
This publication has 58 references indexed in Scilit:
- Human Neuron-Committed Teratocarcinoma NT2 Cell Line Has Abnormal ND10 Structures and Is Poorly Infected by Herpes Simplex Virus Type 1Journal of Virology, 2001
- Lentiviral Vectors: Regulated Gene ExpressionMolecular Therapy, 2000
- Regulatable systems: applications in gene therapy and replicating virusesJournal of Clinical Investigation, 2000
- Design and application of HSV vectors for neuroprotectionGene Therapy, 2000
- Inducible long-term gene expression in brain with adeno-associated virus gene transferGene Therapy, 1998
- Tetracycline-responsive gene expression in mouse brain after amplicon-mediated gene transferGene Therapy, 1997
- Ecdysone-inducible gene expression in mammalian cells and transgenic mice.Proceedings of the National Academy of Sciences, 1996
- An insertion vector for the analysis of gene expression during herpes simplex virus infectionGene, 1990
- Octamer motif mediates transcriptional repression of HSV immediate-early genes and octamer-containing cellular promoters in neuronal cellsNeuron, 1990
- Replication of thymidine kinase deficient herpes simplex virus type 1 in neuronal cell culture: Infection of the PC 12 cellArchiv für die gesamte Virusforschung, 1983